AbbVie's (ABBV) Q1 Earnings and Sales Surpass Estimates
AbbVie Inc. ABBV reported earnings of $2.42 per share in the first quarter, comfortably beating the Zacks Consensus Estimate of $2.27 and came ahead of the guided range of $2.28-$2.30. Earnings rose 16.3% year over year.
Meanwhile, the company’s revenues of $8.62 billion beat the Zacks Consensus Estimate of $8.44 billion. Meanwhile, the top line improved 10.1% year over year.
...
https://finance.yahoo.com/news/abbvies-a...02542.html
AbbVie Inc. ABBV reported earnings of $2.42 per share in the first quarter, comfortably beating the Zacks Consensus Estimate of $2.27 and came ahead of the guided range of $2.28-$2.30. Earnings rose 16.3% year over year.
Meanwhile, the company’s revenues of $8.62 billion beat the Zacks Consensus Estimate of $8.44 billion. Meanwhile, the top line improved 10.1% year over year.
...
https://finance.yahoo.com/news/abbvies-a...02542.html
![[Bild: ABBVc1dl0554.png]](https://finviz.com/publish/050420/ABBVc1dl0554.png)
__________________